At a glance
- Originator Schering-Plough
- Class Analgesics; Antihypertensives
- Mechanism of Action Endopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Hypertension
Most Recent Events
- 25 Aug 2009 Discontinued - Phase-II for Heart failure in USA (unspecified route)
- 25 Aug 2009 Discontinued - Phase-II for Hypertension in USA (unspecified route)
- 18 Dec 2000 Profile reviewed but no significant changes made